DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

NARecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

March 7, 2023

Primary Completion Date

June 7, 2024

Study Completion Date

June 30, 2026

Conditions
HCC
Interventions
PROCEDURE

DEB-TACE and HAIC

Drug-eluting bead transarterial chemoembolization sequential Hepatic Artery Chemotherapy Infusion

PROCEDURE

DEB-TACE

Drug-eluting bead transarterial chemoembolization

Trial Locations (16)

Unknown

RECRUITING

Luo He Central Hospital, Luohe

RECRUITING

Luo Yang Central Hospital, Luoyang

RECRUITING

Deng zhou People's Hospital, Nanyang

RECRUITING

Nan Yang Central Hospital, Nanyang

RECRUITING

General Hospital of Pingmei Shenma Group, Pingdingshan

RECRUITING

First People's Hospital of Shangqiu, Shangqiu

RECRUITING

Shangqiu Municipal Hospital, Shangqiu

RECRUITING

Xin Yang Central Hospital, Xinyang

RECRUITING

The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Zhengzhou Central Hospital, Zhengzhou

RECRUITING

Zhou Kou Central Hospital, Zhoukou

RECRUITING

First People's Hospital of Zhu Madian, Zhumadian

RECRUITING

Zhu Ma Dian Central Hospital, Zhumadian

RECRUITING

Zhu Madian Traditional Chinese Medicine Hospital, Zhumadian

RECRUITING

Second People's Hospital of Jiaozuo, Jiaozuo

All Listed Sponsors
lead

Xuhua Duan

OTHER